127526-60-7

Upstream product

• 123593-66-8 L-N-(tert-butoxycarbonyl)-4-benzyloxyphenylglycine 
• 127526-66-3 3,5-dichloro-L-tyrosine methyl ester 

Downstream Products

• 127526-61-8 (8R,11R,14S)-8-Amino-18,19-dichloro-11-(4-hydroxy-phenyl)-5-iodo-4-methoxy-9,12-dioxo-2-oxa-10,13-diaza-tricyclo[14.2.2.1^3,7]henicosa-1⁽¹⁹⁾,3,5,7⁽²¹⁾,16⁽²⁰⁾,17-hexaene-14-carboxylic acid methyl ester; hydrobromide 
• 126782-54-5 (11R,14S)-8-Benzyloxycarbonylamino-11-(4-benzyloxy-phenyl)-18,19-dichloro-4-hydroxy-5-iodo-9,12-dioxo-2-oxa-10,13-diaza-tricyclo[14.2.2.1^3,7]henicosa-1⁽¹⁹⁾,3,5,7⁽²¹⁾,16⁽²⁰⁾,17-hexaene-14-carboxylic acid methyl ester 
• 126782-53-4 (S)-2-[(R)-2-[(R)-2-Benzyloxycarbonylamino-2-(4-hydroxy-3,5-diiodo-phenyl)-acetylamino]-2-(4-benzyloxy-phenyl)-acetylamino]-3-(3,5-dichloro-4-hydroxy-phenyl)-propionic acid methyl ester 

Relevant academic research and scientific papers

SINTHETIC STUDY ON VANCOMYCIN: SYNTHESIS OF MACROCYCLIC TETRAPEPTIDE AS A PLAUSIBLE ACTIVE CENTER IN VANCOMYCIN

Two macrocyclic peptides included in vancomycin have been synthesized using TTN oxidating method.Of them, the macrocyclic tetrapeptide is regarded as an important moiety of vancomycin which forms a binding pocket for the carboxylate region of the terminal D-Ala-D-alanine.